title: Oxpentifylline treatment of venous ulcers of the leg.
abstract: OBJECTIVE
  To determine the effect of oxpentifylline on the healing of venous ulcers of the leg.
  
  
  METHODS
  Double blind, randomised, prospective, placebo controlled, parallel group study.
  
  
  METHODS
  Four outpatient clinics treating leg ulcers in England and the Republic of Ireland.
  
  
  METHODS
  80 Consecutive patients with clinical evidence of venous ulceration of the leg in whom appreciable arterial disease was excluded by the ratio of ankle to brachial systolic pressure being greater than 0.8.
  
  
  METHODS
  All patients received either oxpentifylline 400 mg three times a day by mouth or a matching placebo for six months (or until their reference ulcer healed if this occurred sooner) in addition to a locally standardised method of compression bandaging.
  
  
  METHODS
  The primary end point was complete healing of the reference ulcer within six months. The secondary end point was the change in the area of the ulcer over the six month observation period.
  
  
  RESULTS
  Complete healing of the reference ulcer occurred in 23 of the 38 patients treated with oxpentifylline and in 12 of the 42 patients treated with a placebo. Life table analysis showed that the proportion of ulcers healed at six months was 64% in the group treated with oxpentifylline compared with 34% in the group treated with a placebo (log rank test chi 2 = 4.78, p = 0.03), which was significant (odds ratio = 1.81, 95% confidence interval 1.20 to 2.71).
  
  
  CONCLUSIONS
  Oxpentifylline used in conjunction with compression bandaging improves the healing of venous ulcers of the leg.
authors: Vascular Laboratories, St James's Hospital, Dublin.
authors: M P
authors: MP
authors: Colgan
authors: J A
authors: JA
authors: Dormandy
authors: P W
authors: PW
authors: Jones
authors: I G
authors: IG
authors: Schraibman
authors: D G
authors: DG
authors: Shanik
authors: R A
authors: RA
authors: Young
mesh_terms: D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010431:Pentoxifylline / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013805:Theobromine / Q000031:analogs & derivatives*; D014647:Varicose Ulcer / Q000188:drug therapy* / Q000473:pathology; D014945:Wound Healing
chemical_list: D013805:Theobromine; D010431:Pentoxifylline